— Know what they know.
Not Investment Advice

CNTMF OTC

Fluent Corp.
1W: +0.1% 1M: +0.9% 3M: +2.2% YTD: -56.8% 1Y: -57.4% 3Y: -74.4% 5Y: -96.6%
$0.02
+0.00 (+0.00%)
 
Weekly Expected Move ±13.3%
$0 $0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 50 · $10.8M mcap · 146M float · 0.230% daily turnover · Short 50% of daily vol

Cash Flow Trends

Operating Cash Flow
$2M -90.4% ▼
Capital Expenditures
$18M -176.2% ▼
5Y CAGR: +4.3%
Free Cash Flow
-$16M -229.8% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$30M +1268.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$37M-$19M-$37M-$23M-$40M
Depreciation & Amort.$8M$10M$13M$15M$15M
Stock-Based Comp.$6M$4M$545K$638K$538K
Change in Working Capital$10M-$16M$6M$8M-$28M
Other Non-Cash Items$23M$17M$38M$21M$24M
Operating Cash Flow$8M-$5M$19M$18M$2M
— Investing Activities —
Capital Expenditures-$5M-$21M-$7M-$6M-$16M
Acquisitions (Net)$600K$0$0$0$40M
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing-$1M-$732K$25K-$319K-$1M
Investing Cash Flow-$6M-$22M-$7M-$6M$22M
— Financing Activities —
Net Debt Issuance-$5M$4M-$13M-$13M$7M
Stock Repurchased-$1M$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$4M$10M$297K$0$0
Financing Cash Flow-$2M$33M-$13M-$10M$7M
Net Change in Cash$876K$6M-$665K$2M$30M
Cash End of Period$3M$9M$8M$11M$40M
Free Cash Flow$3M-$26M$12M$12M-$16M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms